Researchers Awarded Federal Grant to Lead Multicenter Study of Stem Cell Transplant Complication
The National Heart, Lung and Blood Institute has awarded a $3.87 million, five-year grant to help OSUCCC – James researchers lead a multicenter study of thrombotic microangiopathy, a severe and life-threatening complication in patients undergoing hematopoietic stem cell transplant as treatment for blood cancers.
Principal investigator (PI) for this R01 grant study—titled MIDAS: Microangiopathy, Endothelial Damage in Adults Undergoing Stem Cell Transplantation—is Sumithira Vasu, MBBS, associate professor – clinical in the Division of Hematology at The Ohio State University College of Medicine and member of the Leukemia Research Program at the OSUCCC – James. Spero Cataland, MD, professor in the Division of Hematology, is co-PI.
